论文部分内容阅读
Doxorubicin (DOX) is a widely used chemotherapeutic drug for the treatment of several types of cancers.However,its side effects and the development of multidrug resistance (MDR) greatly reduced the antitumor efficacy.There are many mechanisms responsible for MDR and the overexpression of P-glycoprotein (P-gp) plays a major role in mediating MDR.